Verrica Pharmaceuticals Inc

NASDAQ:VRCA

0.71

+0.06 (+9.01%)

4:25:59 PM EDT: $0.65 -0.05 (-7.33%)

Market Cap (Intraday)	71.25M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$4.19 Million
Adjusted EPS	-$0.08

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Verrica Pharmaceuticals Inc Stock, NASDAQ:VRCA

44 West Gay Street, Suite 400, West Chester, Pennsylvania 19380

United States of America

Phone: +1.434.453.3300

Number of Employees: 71

http://www.verrica.com

Description

Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.